Further survival analysis using the GEPIA2 database showed that BCL2, BAK (Figure 1C), BIM, and PUMA (Supplementary Figure 1B) were negatively associated with overall survival (OS) in AML. The gene discussed is BCL2; the disease is acute myeloid leukemia.